NCI Research Specialist (Clinician Scientist) Award (R50 Clinical Trial Not Allowed)

The National Cancer Institute (NCI) is inviting grant applications for the Research Specialist Award (R50) specifically for clinician scientists supporting NCI-funded clinical trials research. This award is designed to encourage the development of stable research career opportunities for exceptional clinician scientists who want to continue to participate in the NCI clinical trials networks through leadership in the development of clinical trials, implementation of NCI clinical trials in their institutions, and national service to the NCI clinical trials networks. * The award is intended to provide salary support and sufficient autonomy so that individuals are not solely dependent on NCI grants held by others or other sources of support for cancer research career continuity. * Applications are limited to four per institution per receipt date, including new and resubmissions. * NCI seeks a broad representation of institutions for this award mechanism and may take this into account when making funding decisions. * The award is expected to be published in late summer 2024 with only one expected application due date of November 5, 2024.